Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis

The discovery of signaling networks that drive oncogenic processes has led to the development of targeted anticancer agents. The burden of pigmentary adverse events from these drugs is unknown.

http://ift.tt/2h5lA8r